Henry Schein, Inc. (NASDAQ:HSIC) Shares Bought by Natixis Advisors LLC

Natixis Advisors LLC lifted its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 18.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 81,877 shares of the company’s stock after buying an additional 12,930 shares during the quarter. Natixis Advisors LLC’s holdings in Henry Schein were worth $5,969,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in HSIC. Thompson Siegel & Walmsley LLC purchased a new position in Henry Schein during the second quarter valued at $46,683,000. SG Americas Securities LLC raised its position in shares of Henry Schein by 1,622.3% during the 3rd quarter. SG Americas Securities LLC now owns 458,828 shares of the company’s stock worth $33,449,000 after purchasing an additional 432,187 shares during the last quarter. Sei Investments Co. lifted its stake in Henry Schein by 8.0% in the 2nd quarter. Sei Investments Co. now owns 420,957 shares of the company’s stock valued at $26,983,000 after buying an additional 31,168 shares in the last quarter. MBB Public Markets I LLC purchased a new stake in Henry Schein during the 2nd quarter worth approximately $611,000. Finally, Marathon Asset Management Ltd lifted its position in shares of Henry Schein by 3.2% in the third quarter. Marathon Asset Management Ltd now owns 279,203 shares of the company’s stock valued at $20,354,000 after acquiring an additional 8,742 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Insider Activity at Henry Schein

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. This trade represents a 22.65 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at $6,577,950. This represents a 12.25 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of research firms have recently issued reports on HSIC. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Barrington Research reaffirmed an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a research note on Wednesday, November 6th. JPMorgan Chase & Co. lowered their target price on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. Evercore ISI upped their price target on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. Finally, UBS Group lowered their price objective on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $78.89.

Henry Schein Price Performance

Henry Schein stock opened at $75.08 on Friday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The company has a market capitalization of $9.36 billion, a price-to-earnings ratio of 30.78, a price-to-earnings-growth ratio of 2.15 and a beta of 0.87. The company’s 50 day simple moving average is $70.80 and its 200-day simple moving average is $69.72. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.63.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. During the same period in the prior year, the firm earned $1.32 earnings per share. The firm’s revenue was up .4% compared to the same quarter last year. As a group, equities research analysts expect that Henry Schein, Inc. will post 4.78 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.